Variant report

Variant	nsv981078
Chromosome Location	chr6:113851437-113874497
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr6:113852008-113852231	HepG2	liver:	n/a	n/a
2	BHLHE40	chr6:113852021-113852297	HepG2	liver:	n/a	n/a
3	CBX3	chr6:113851965-113852322	K562	blood:	n/a	n/a
4	CEBPB	chr6:113852010-113852337	IMR90	lung:	n/a	n/a
5	CEBPB	chr6:113851939-113852326	MCF-7	breast:	n/a	n/a
6	CEBPB	chr6:113852071-113852292	HepG2	liver:	n/a	n/a
7	CEBPB	chr6:113861761-113862089	IMR90	lung:	n/a	n/a
8	CHD1	chr6:113852206-113852260	H1-hESC	embryonic stem cell:	n/a	n/a
9	CHD2	chr6:113852187-113852252	HepG2	liver:	n/a	n/a
10	E2F4	chr6:113852112-113852312	MCF10A-Er-Src	breast:	n/a	n/a
11	E2F6	chr6:113851979-113852411	H1-hESC	embryonic stem cell:	n/a	n/a
12	EP300	chr6:113860651-113860974	SK-N-SH_RA	brain:	n/a	chr6:113860812-113860821
13	EP300	chr6:113861368-113862276	SK-N-SH	brain:	n/a	n/a
14	EP300	chr6:113852052-113852136	HepG2	liver:	n/a	n/a
15	EP300	chr6:113861560-113862334	SK-N-SH	brain:	n/a	n/a
16	EP300	chr6:113861638-113861970	SK-N-SH_RA	brain:	n/a	n/a
17	EP300	chr6:113860545-113861150	SK-N-SH_RA	brain:	n/a	chr6:113860812-113860821
18	EP300	chr6:113851985-113852361	MCF-7	breast:	n/a	n/a
19	FOS	chr6:113860911-113861200	MCF10A-Er-Src	breast:	n/a	chr6:113861056-113861068 chr6:113861112-113861121 chr6:113861059-113861070 chr6:113861057-113861067 chr6:113861058-113861066 chr6:113861057-113861067
20	FOS	chr6:113861871-113861957	MCF10A-Er-Src	breast:	n/a	n/a
21	FOS	chr6:113852007-113852366	MCF10A-Er-Src	breast:	n/a	chr6:113852186-113852195 chr6:113852184-113852196 chr6:113852184-113852195
22	FOS	chr6:113851949-113852417	MCF10A-Er-Src	breast:	n/a	chr6:113852186-113852195 chr6:113852184-113852196 chr6:113852184-113852195
23	FOS	chr6:113861894-113861905	MCF10A-Er-Src	breast:	n/a	n/a
24	FOS	chr6:113852008-113852313	HUVEC	blood vessel:	n/a	chr6:113852186-113852195 chr6:113852184-113852196 chr6:113852184-113852195
25	FOS	chr6:113852000-113852424	MCF10A-Er-Src	breast:	n/a	chr6:113852186-113852195 chr6:113852184-113852196 chr6:113852184-113852195
26	FOS	chr6:113851956-113852384	MCF10A-Er-Src	breast:	n/a	chr6:113852186-113852195 chr6:113852184-113852196 chr6:113852184-113852195
27	FOSL2	chr6:113851919-113852315	A549	lung:	n/a	chr6:113852185-113852196 chr6:113852186-113852195 chr6:113852184-113852196
28	FOSL2	chr6:113851957-113852372	HepG2	liver:	n/a	chr6:113852185-113852196 chr6:113852186-113852195 chr6:113852184-113852196
29	FOSL2	chr6:113852014-113852397	HepG2	liver:	n/a	chr6:113852185-113852196 chr6:113852186-113852195 chr6:113852184-113852196
30	FOSL2	chr6:113861530-113862190	SK-N-SH	brain:	n/a	n/a
31	FOSL2	chr6:113860775-113861364	SK-N-SH	brain:	n/a	chr6:113861056-113861068 chr6:113861112-113861121 chr6:113861059-113861070 chr6:113861057-113861067 chr6:113861058-113861066 chr6:113861057-113861067
32	FOSL2	chr6:113851950-113852313	SK-N-SH	brain:	n/a	chr6:113852185-113852196 chr6:113852186-113852195 chr6:113852184-113852196
33	FOSL2	chr6:113851915-113852400	MCF-7	breast:	n/a	chr6:113852185-113852196 chr6:113852186-113852195 chr6:113852184-113852196
34	FOXA1	chr6:113861791-113862066	ECC-1	luminal epithelium:	n/a	n/a
35	FOXA1	chr6:113861855-113861995	T-47D	breast:	n/a	n/a
36	FOXA1	chr6:113861775-113862090	ECC-1	luminal epithelium:	n/a	n/a
37	FOXA2	chr6:113852460-113853064	A549	lung:	n/a	n/a
38	FOXA2	chr6:113852554-113853004	A549	lung:	n/a	n/a
39	FOXM1	chr6:113861634-113862136	SK-N-SH	brain:	n/a	n/a
40	GATA2	chr6:113862939-113863210	SH-SY5Y	brain:	n/a	n/a
41	GATA3	chr6:113851738-113852446	MCF-7	breast:	n/a	chr6:113852184-113852193
42	GATA3	chr6:113860462-113861352	SK-N-SH	brain:	n/a	chr6:113861059-113861068
43	GATA3	chr6:113861396-113862322	SK-N-SH	brain:	n/a	n/a
44	GATA3	chr6:113851943-113852380	MCF-7	breast:	n/a	chr6:113852184-113852193
45	GATA3	chr6:113860480-113861291	SK-N-SH	brain:	n/a	chr6:113861059-113861068
46	GATA3	chr6:113861526-113862276	SK-N-SH	brain:	n/a	n/a
47	HDAC2	chr6:113851970-113852367	MCF-7	breast:	n/a	n/a
48	HEY1	chr6:113852290-113852737	K562	blood:	n/a	n/a
49	HEY1	chr6:113852525-113852725	K562	blood:	n/a	n/a
50	HNF4A	chr6:113851999-113852250	HepG2	liver:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:113860384-113860434	MCF10A-Er-Src	breast:	n/a
2	chr6:113852589-113852639	RPTEC	kidney:	n/a
3	chr6:113860384-113860434	HNPCEpiC	eye:	n/a
4	chr6:113852589-113852639	HNPCEpiC	eye:	n/a
5	chr6:113852490-113852540	Hela-S3	cervix:	n/a
6	chr6:113860384-113860434	Caco-2	colon:	n/a
7	chr6:113852490-113852540	AG09319	gingival:	n/a
8	chr6:113860384-113860434	SAEC	small airway:	n/a
9	chr6:113852589-113852639	Caco-2	colon:	n/a
10	chr6:113852589-113852639	Jurkat	blood:	n/a
11	chr6:113852589-113852639	K562	blood:	n/a
12	chr6:113852490-113852540	A549	lung:	n/a
13	chr6:113852589-113852639	IMR90	lung:	fetal
14	chr6:113860384-113860434	BJ	skin:	n/a
15	chr6:113860384-113860434	HUVEC	blood vessel:	n/a
16	chr6:113852490-113852540	HCPEpiC	choroid plexus:	n/a
17	chr6:113852490-113852540	NH-A	brain:	n/a
18	chr6:113852589-113852639	GM12892	blood:	n/a
19	chr6:113852589-113852639	H1-hESC	embryonic stem cell:	embryo
20	chr6:113852490-113852540	PANC-1	pancreas:	n/a
21	chr6:113852589-113852639	GM12878	blood:	n/a
22	chr6:113860384-113860434	SK-N-SH_RA	brain:	n/a
23	chr6:113852490-113852540	HCT-116	colon:	n/a
24	chr6:113852589-113852639	PANC-1	pancreas:	n/a
25	chr6:113852490-113852540	NHBE	bronchial:	n/a
26	chr6:113860384-113860434	Jurkat	blood:	n/a
27	chr6:113852589-113852639	HRCEpiC	kidney:	n/a
28	chr6:113860384-113860434	HCF	heart:	n/a
29	chr6:113852589-113852639	HRPEpiC	eye:	n/a
30	chr6:113860384-113860434	NHDF-neo	bronchial:	n/a
31	chr6:113852589-113852639	SK-N-SH_RA	brain:	n/a
32	chr6:113852589-113852639	HCM	heart:	n/a
33	chr6:113852589-113852639	HRE	kidney:	n/a
34	chr6:113852589-113852639	HIPEpiC	eye:	n/a
35	chr6:113852490-113852540	SKMC	muscle:	n/a
36	chr6:113852490-113852540	BJ	skin:	n/a
37	chr6:113860384-113860434	ProgFib	skin:	n/a
38	chr6:113860384-113860434	AG04450	lung:	fetal
39	chr6:113852490-113852540	HCF	heart:	n/a
40	chr6:113852490-113852540	GM12892	blood:	n/a
41	chr6:113852490-113852540	CMK	blood:	n/a
42	chr6:113852490-113852540	BE2_C	brain:	n/a
43	chr6:113852490-113852540	RPTEC	kidney:	n/a
44	chr6:113852589-113852639	CMK	blood:	n/a
45	chr6:113860384-113860434	SK-N-MC	brain:	n/a
46	chr6:113852490-113852540	U87	brain:	n/a
47	chr6:113852490-113852540	GM12891	blood:	n/a
48	chr6:113852589-113852639	GM06990	blood:	n/a
49	chr6:113860384-113860434	Hela-S3	cervix:	n/a
50	chr6:113860384-113860434	LNCaP	prostate:	n/a

No.	Distal block	Cell Line	Cell type
1	chr6:113861736..113863744-chr6:113866553..113868522,2	MCF-7	breast:
2	chr6:113863525..113865687-chr6:113866554..113868248,2	K562	blood:
3	chr6:113857236..113859852-chr6:113862188..113865011,2	MCF-7	breast:
4	chr6:113861736..113863744-chr6:113866553..113868522,2	MCF-7	breast:
5	chr6:113847511..113849509-chr6:113849941..113851506,2	MCF-7	breast:
6	chr6:113863525..113865687-chr6:113866554..113868248,2	K562	blood:
7	chr6:113857236..113859852-chr6:113862188..113865011,2	MCF-7	breast:
8	chr11:47916274..47916775-chr6:113873100..113873600,2	NB4	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-HDAC2-12	chr6:113856446-113856873	NONHSAT114548
2	lnc-HDAC2-12	chr6:113861232-113861316	NONHSAT114547
3	lnc-MARCKS-4	chr6:113852320-113852460	XLOC_005437
4	lnc-MARCKS-4	chr6:113864604-113864995	NONHSAT114545
5	lnc-MARCKS-4	chr6:113863039-113863103	XLOC_005437
6	lnc-MARCKS-4	chr6:113864605-113864995	XLOC_005437
7	lnc-MARCKS-4	chr6:113863038-113863103	NONHSAT114545
8	lnc-HDAC2-12	chr6:113856398-113856873	l_3236_chr6:113856397-113861313_placenta
9	lnc-HDAC2-12	chr6:113861232-113861313	l_3236_chr6:113856397-113861313_placenta
10	lnc-HDAC2-12	chr6:113860454-113860536	NONHSAT114548
11	lnc-MARCKS-4	chr6:113852319-113852460	NONHSAT114545
12	lnc-HDAC2-12	chr6:113856435-113856873	NONHSAT114547

Variant related genes	Relation type
ENSG00000236347	TF binding region
ENSG00000236347	CpG island

Extended variants
information (count: 577 )
Associated
traits (count: 119 )

Variant overlapped rSNPs/rCNVs (count:577 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs576574228	chr6:113851446-113851447	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs562223418	chr6:113851447-113851448	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs544422455	chr6:113851455-113851456	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs562632291	chr6:113851523-113851524	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs533026254	chr6:113851524-113851525	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs577757654	chr6:113851541-113851542	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs11441711	chr6:113851543-113851544	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs397948609	chr6:113851544-113851545	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs377380608	chr6:113851633-113851634	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs6942149	chr6:113851652-113851653	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs113193231	chr6:113851675-113851676	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs113518785	chr6:113851693-113851694	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs143256529	chr6:113851722-113851723	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs560053156	chr6:113851739-113851740	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs560671344	chr6:113851746-113851747	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs372520313	chr6:113851774-113851775	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs549974365	chr6:113851811-113851812	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs571551726	chr6:113851834-113851835	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs375019272	chr6:113851856-113851857	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs551772166	chr6:113851868-113851869	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs183617777	chr6:113851901-113851902	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs77169785	chr6:113851938-113851939	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs75219418	chr6:113851947-113851948	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs566326526	chr6:113851991-113851992	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs536269920	chr6:113852033-113852034	Flanking Active TSS Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs554953209	chr6:113852034-113852035	Flanking Active TSS Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs116978763	chr6:113852055-113852056	Flanking Active TSS Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs537582625	chr6:113852060-113852061	Flanking Active TSS Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs550705791	chr6:113852064-113852065	Flanking Active TSS Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs569197421	chr6:113852090-113852091	Flanking Active TSS Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs577789075	chr6:113852102-113852103	Flanking Active TSS Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs545174501	chr6:113852118-113852119	Flanking Active TSS Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs560204100	chr6:113852157-113852158	Flanking Active TSS Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs527588926	chr6:113852195-113852196	Flanking Active TSS Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs189443029	chr6:113852198-113852199	Flanking Active TSS Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs73765261	chr6:113852206-113852207	Flanking Active TSS Active TSS Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs542218712	chr6:113852210-113852211	Flanking Active TSS Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs560511070	chr6:113852252-113852253	Flanking Active TSS Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs531201070	chr6:113852262-113852263	Flanking Active TSS Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs549514084	chr6:113852320-113852321	Flanking Active TSS Active TSS Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
41	rs116058204	chr6:113852326-113852327	Flanking Active TSS Active TSS Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
42	rs139305542	chr6:113852335-113852336	Flanking Active TSS Active TSS Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
43	rs144081616	chr6:113852340-113852341	Flanking Active TSS Active TSS Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
44	rs549272864	chr6:113852343-113852344	Flanking Active TSS Active TSS Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
45	rs566242865	chr6:113852345-113852346	Flanking Active TSS Active TSS Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
46	rs536906005	chr6:113852346-113852347	Flanking Active TSS Active TSS Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
47	rs371005105	chr6:113852356-113852357	Flanking Active TSS Active TSS Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
48	rs548889276	chr6:113852369-113852370	Flanking Active TSS Active TSS Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
49	rs151019633	chr6:113852405-113852406	Active TSS Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
50	rs537419103	chr6:113852422-113852423	Active TSS Enhancers	lncRNA	n/a	Overlapped CNVs	n/a

Variant related diseases (count:119)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Autism	22495311	CNVD
Gastric cancer	17908304	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Colorectal cancer	16272173	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
T-cell lymphomas	19863542	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Ependymoma	16718352	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Prostate cancer	18632612	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Urothelial carcinoma	18382360	CNVD
Ovarian neoplasms	16753589	CNVD
Hepatocellular carcinoma	16750200	CNVD
Wilms tumour	21544195	CNVD
Leukemia	18688285	CNVD
Prostate cancer	19242612	CNVD
Glioma	21046410	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Zellweger syndrome	21572526	CNVD
Follicular lymphoma	20505157	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Lung adenocarcinoma	21935476	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Chondromyxoid Fibroma	20696777	CNVD
Cancer	21183584	CNVD
Developmental delay	19490664	CNVD
Non-muscle invasive bladder neoplasm	19445696	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Burkitt''s lymphoma	18698080	CNVD
Ovarian cancer	21720365	CNVD
Basal cell lymphoma	17170743	CNVD
Prostate cancer	16573809	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Breast cancer	21785460	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Prostate cancer	16461572	CNVD
Neurocytoma	17123091	CNVD
Cancer	20164920	CNVD
Breast cancer	21364760	CNVD
Myelofibrosis	22110671	CNVD
Chronic lymphocytic leukemia	17805327	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Autism	17483303	CNVD
Chordoma	21602918	CNVD
Kartagener syndrome	16639409	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Systemic lupus erythematosus	19220326	CNVD
Cancer	17160897	CNVD
Autism	19546859	CNVD
Schizophrenia	19546859	CNVD
Tourette syndrome	19546859	CNVD
Acute lymphoblastic leukemia	17229543	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	17133270	CNVD
Follicular lymphoma	18703704	CNVD
Mental retardation	17621639	CNVD
Hypoplastic	20877625	CNVD
Hypotonia	20877625	CNVD
Mental retardation	20877625	CNVD
Microcephaly	20877625	CNVD
brachycephaly	20877625	CNVD
epicanthic folds	20877625	CNVD
micrognathia	20877625	CNVD
small cell lung cancer	20016488	CNVD
Urothelial carcinoma	21177765	CNVD
Schizophrenia	23813976	CNVD

Chromatin state (count:84 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:113846800-113851800	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
2	chr6:113849600-113852400	Enhancers	HMEC	breast
3	chr6:113850200-113852400	Enhancers	Muscle Satellite Cultured Cells	--
4	chr6:113850200-113852400	Enhancers	NHDF-Ad	bronchial
5	chr6:113850200-113852600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
6	chr6:113850400-113852000	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
7	chr6:113850800-113852000	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
8	chr6:113851000-113852000	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
9	chr6:113851000-113852000	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
10	chr6:113851000-113852000	Weak transcription	NHLF	lung
11	chr6:113851000-113852000	Weak transcription	Osteobl	bone
12	chr6:113851000-113852200	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
13	chr6:113851200-113851600	Weak transcription	NHEK	skin
14	chr6:113851400-113851800	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
15	chr6:113851400-113852800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
16	chr6:113851600-113852200	Enhancers	NHEK	skin
17	chr6:113851800-113852000	Enhancers	ES-I3 Cell Line	embryonic stem cell
18	chr6:113851800-113852200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
19	chr6:113851800-113852400	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
20	chr6:113852000-113852200	Enhancers	HUES6 Cell Line	embryonic stem cell
21	chr6:113852000-113852200	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
22	chr6:113852000-113852200	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
23	chr6:113852000-113852200	Enhancers	NHLF	lung
24	chr6:113852000-113852400	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
25	chr6:113852000-113852400	Active TSS	ES-WA7 Cell Line	embryonic stem cell
26	chr6:113852000-113852400	Enhancers	iPS-15b Cell Line	embryonic stem cell
27	chr6:113852000-113852400	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
28	chr6:113852000-113852400	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
29	chr6:113852000-113852400	Enhancers	HepG2	liver
30	chr6:113852000-113852400	Enhancers	NH-A	brain
31	chr6:113852000-113852400	Enhancers	Osteobl	bone
32	chr6:113852000-113852600	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
33	chr6:113852200-113852600	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
34	chr6:113852200-113852800	Active TSS	HUES6 Cell Line	embryonic stem cell
35	chr6:113852400-113852800	Active TSS	ES-I3 Cell Line	embryonic stem cell
36	chr6:113852400-113852800	Active TSS	iPS-15b Cell Line	embryonic stem cell
37	chr6:113859800-113860200	Enhancers	Muscle Satellite Cultured Cells	--
38	chr6:113859800-113861000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
39	chr6:113859800-113861000	Enhancers	HUES64 Cell Line	embryonic stem cell
40	chr6:113859800-113861000	Enhancers	HSMMtube	muscle
41	chr6:113859800-113861600	Enhancers	Fetal Heart	heart
42	chr6:113859800-113862200	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
43	chr6:113860000-113860400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
44	chr6:113860000-113860600	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
45	chr6:113860000-113861000	Enhancers	HUES48 Cell Line	embryonic stem cell
46	chr6:113860000-113861000	Enhancers	iPS-15b Cell Line	embryonic stem cell
47	chr6:113860000-113862200	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
48	chr6:113860000-113862400	Enhancers	NHDF-Ad	bronchial
49	chr6:113860000-113862400	Enhancers	Osteobl	bone
50	chr6:113860200-113860400	Flanking Active TSS	Muscle Satellite Cultured Cells	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links